We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.7%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$428M
AUM Growth
+$195M
Cap. Flow
+$159M
Cap. Flow %
37.3%
Top 10 Hldgs %
62.38%
Holding
48
New
8
Increased
15
Reduced
15
Closed
5

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.18M
2
BDX icon
Becton Dickinson
BDX
+$3.81M
3
CTLT
CATALENT, INC.
CTLT
+$3.07M
4
EHC icon
Encompass Health
EHC
+$2.82M
5
CRL icon
Charles River Laboratories
CRL
+$2.59M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.38M
2
A icon
Agilent Technologies
A
+$5.53M
3
WAT icon
Waters Corp
WAT
+$4.64M
4
UNH icon
UnitedHealth
UNH
+$3.67M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$3.24M

Sector Composition

Rank Sector Weight
1 Healthcare 53.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$820B
$177M 41.47%
+400,000
New +$168M
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$20.8M 4.87%
250,000
+50,000
+25% +$4.18M
THC icon
3
Tenet Healthcare
THC
$21B
$11.4M 2.66%
140,000
-10,000
-7% -$712K
BSX icon
4
Boston Scientific
BSX
$71.9B
$8.65M 2.02%
160,000
+5,000
+3% +$261K
UHS icon
5
Universal Health Services
UHS
$10.3B
$8.28M 1.94%
52,500
-2,490
-5% -$347K
LLY icon
6
Eli Lilly
LLY
$1.06T
$8.21M 1.92%
17,500
-2,500
-13% -$1.05M
NVO
7
Novo Nordisk
NVO
$208B
$8.09M 1.89%
100,000
-20,000
-17% -$1.63M
CAH icon
8
Cardinal Health
CAH
$55.8B
$8.04M 1.88%
85,000
+5,000
+6% +$422K
ZBH icon
9
Zimmer Biomet
ZBH
$18.3B
$8.01M 1.87%
55,000
-5,000
-8% -$679K
BDX icon
10
Becton Dickinson
BDX
$48.5B
$7.92M 1.85%
30,000
+15,000
+100% +$3.81M
SGRY icon
11
Surgery Partners
SGRY
$2.01B
$7.87M 1.84%
175,000
– –
HUM icon
12
Humana
HUM
$45.2B
$7.83M 1.83%
17,500
-5,000
-22% -$2.52M
COR icon
13
Cencora
COR
$61.8B
$7.7M 1.8%
40,000
– –
ISRG icon
14
Intuitive Surgical
ISRG
$133B
$7.69M 1.8%
22,500
-7,500
-25% -$2.27M
SYK icon
15
Stryker
SYK
$129B
$7.63M 1.78%
25,000
– –
HCA icon
16
HCA Healthcare
HCA
$88.4B
$7.59M 1.77%
25,000
-5,000
-17% -$1.39M
MCK icon
17
McKesson
MCK
$101B
$7.48M 1.75%
17,500
+2,500
+17% +$961K
BAX icon
18
Baxter International
BAX
$14.1B
$7.29M 1.71%
160,000
+10,000
+7% +$435K
EHC icon
19
Encompass Health
EHC
$12.4B
$6.77M 1.58%
99,976
+44,976
+82% +$2.82M
ELV icon
20
Elevance Health
ELV
$85.1B
$6.66M 1.56%
15,000
+4,457
+42% +$2.06M
ABT icon
21
Abbott
ABT
$186B
$6.54M 1.53%
60,000
+15,000
+33% +$1.6M
IQV icon
22
IQVIA
IQV
$38.6B
$6.18M 1.45%
27,500
+7,500
+38% +$1.51M
SEM
23
DELISTED
Select Medical
SEM
$6.05M 1.42%
352,640
+152,493
+76% +$2.36M
DHR icon
24
Danaher
DHR
$142B
$6M 1.4%
28,200
+5,640
+25% +$1.19M
MRK icon
25
Merck
MRK
$315B
$5.77M 1.35%
50,000
-25,000
-33% -$2.84M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
AIP
Alapocas Investment Partners Beverly, Massachusetts $132M AUM 4.94% 1-Year Est. Return
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2023 Portfolio in Review

As of Q2 2023, Sivik Global Healthcare held 48 positions worth $428M, up 84% from $233M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sivik Global Healthcare deployed $159M of net new capital in Q2 2023, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was CATALENT, INC.: 70,000 shares worth $3.04M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 93% a quarter earlier.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.67M trimmed.

  • Sivik Global Healthcare's largest Q2 2023 buy was CATALENT, INC.: 70,000 shares worth $3.04M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $4.18M increase.
  • Sivik Global Healthcare's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $3.67M.
  • Sivik Global Healthcare fully exited AbbVie in Q2 2023, selling an estimated $6.38M.
  • Sivik Global Healthcare's ten largest holdings make up 62% of its $428M portfolio in Q2 2023.
  • Sivik Global Healthcare opened 8 new positions and closed 5 in Q2 2023.
  • Sivik Global Healthcare's portfolio value rose 84% quarter-over-quarter to $428M.

Based on Sivik Global Healthcare's 13F filing for Q2 2023, filed 9 Aug 2023.